Previous close | 2.0400 |
Open | 2.1000 |
Bid | 2.1100 x 100 |
Ask | 2.3300 x 100 |
Day's range | 2.0500 - 2.3706 |
52-week range | 1.9270 - 19.2000 |
Volume | |
Avg. volume | 137,672 |
Market cap | 2.483M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -3.2700 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Roseland, NJ, July 24, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has finalized partnerships with premier testing laboratories. “As we move closer to commercial launch, we are incredibly excited about these partnerships, which represent a significant step forward in our ability to offer highly personalized health and wellness solutions,” said Vadim Mats, CEO
Roseland, NJ, July 10, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it partnered with Meshy to deliver 3D assets in its AI solution for game developers and publishers. “We are happy to announce our partnership with Meshy to deliver quality 3D models through our product,” said Vadim Mats, CEO of Gaxos.AI. “We look forward to working with Meshy to make our product and servic
Roseland, NJ, June 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that its gaming division, has successfully completed development of its AI solution for game developers and publishers. “We are extremely pleased with our AI solution. We are providing game developers and publishers the ability to embed a new source of revenue within their games as well as a tool to expedite de